Belay Diagnostics Signs 4,000 SF Lease at Fulton Labs in Chicago

CHICAGO — Belay Diagnostics has signed a 4,000-square-foot lease within the science-ready lab suites at Fulton Labs in Chicago. The company, which uses a proprietary molecular testing platform licensed from Johns Hopkins to revolutionize how brain and spinal cord cancers are detected, will move into the fifth-floor space beginning in September. The science-ready lab suites at Fulton Labs are move-in ready private labs spanning 3,000 to 7,000 square feet. Dan Lyne and Kelsey Scheive of CBRE represented ownership, Trammell Crow Co.